PRQR
ProQR Therapeutics BV
1.60$
+0.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +13.4% | -5.1% | +2.9% | -3.2% | -2.5% | +1.0% | -0.4% | -0.6% | +0.2% | +3.2% | +3.6% | – | |
| – | +80.6% | -8.2% | -14.7% | -2.5% | -7.2% | +33.5% | +19.9% | +22.9% | +10.1% | +16.1% | -4.9% | – | |
| – | – | -501.7% | – | – | -148.6% | – | – | – | – | – | -5,466.9% | – | |
| – | +77.6% | +21.6% | -63.5% | +7.1% | -53.5% | +68.4% | -54.9% | +67.3% | +207.2% | -68.4% | +79.7% | – | |
| – | – | -454.6% | -98.5% | – | -116.7% | -92.0% | -54.9% | +67.3% | +207.2% | -68.4% | +79.7% | – | |
| – | – | – | – | – | -44.3% | +124.1% | -48.3% | +51.5% | +35.4% | -49.4% | +104.3% | – | |
| – | +288.6% | -61.6% | -32.7% | +60.6% | – | -100.7% | -41.4% | +51.5% | +32.5% | -48.3% | – | – | |
| – | – | – | – | – | +475.3% | -128.3% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.